In addition, extracorporeal photopheresis (ECP), which is superior to other strategies because of the lack of bioactive materials, has been adopted to cure GVHD in the clinic, as ECP enhances the generation of both CD4+ and CD8+ Tregs (99). The gene discussed is CD8A; the disease is graft versus host disease.